34 results
8-K
EX-99.1
THER
Theralink Technologies, Inc.
15 Sep 11
PediatRx appoints Paul J. Richardson to Board of Directors
12:00am
of success coupled with his experience and insight should contribute significantly to the oversight and operations of PediatRx,” said Dr. Cameron Durrant … the company’s expectation that Mr. Richardson’s track record of success and experience should contribute significantly to the oversight and operations
8-K
EX-99.1
THER
Theralink Technologies, Inc.
29 Jun 23
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
4:01pm
genes associated with increased risk of breast and ovarian cancer; provided oversight for tests used to detect mutations in genes associated with Lynch
8-K
THER
Theralink Technologies, Inc.
29 Jun 23
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
4:01pm
genes associated with increased risk of breast and ovarian cancer; provided oversight for tests used to detect mutations in genes associated with Lynch
8-K
EX-99.1
THER
Theralink Technologies, Inc.
28 Jul 10
Entry into a Material Definitive Agreement
12:00am
Accounting Oversight Board (United States). Those standards required that we plan and perform the audits to obtain reasonable assurance about whether
8-K/A
EX-99.1
THER
Theralink Technologies, Inc.
2 Jul 18
Index to Financial Statements
4:05pm
with the standards of the Public Company Accounting Oversight Board (United States) and in accordance with auditing standards generally accepted
10-K
u4nd3jpjhtek9ye7eg9
22 May 09
Annual report
12:00am
8-K
EX-10.3
5xyk931j5
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm